Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent Mechanism
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The insulin-like growth factor (IGF) signaling pathway plays a crucial role in the regulation of cell growth, differentiation, apoptosis, and aging. IGF-binding proteins (IGFBPs) are important members of the IGF axis. IGFBP-5 is up-regulated during cellular senescence in human dermal fibroblasts and endothelial cells, but the function of IGFBP-5 in cellular senescence is unknown. Here we show that IGFBP-5 plays important roles in the regulation of cellular senescence. Knockdown of IGFBP-5 in old human umbilical endothelial cells (HUVECs) with IGFBP-5 micro-RNA lentivirus caused partial reduction of a variety of senescent phenotypes, such as changes in cell morphology, increases in cell proliferation, and decreases in senescence-associated β-galactosidase (SA-β-gal) staining. In addition, treatment with IGFBP-5 protein or up-regulation of IGFBP-5 in young cells accelerates cellular senescence, as confirmed by cell proliferation and SA-β-gal staining. Premature senescence induced by IGFBP-5 up-regulation in young cells was rescued by knockdown of p53, but not by knockdown of p16. Furthermore, atherosclerotic arteries exhibited strong IGFBP-5–positive staining along intimal plaques. These results suggest that IGFBP-5 plays a role in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3 was similarly described to be essential for both the early ROS increase, as well as the later senescence-associated-β-galactosidase activity, through STAT3-regulated soluble factor insulin-like growth factor binding protein 5 in both human fibroblasts (Udono et al., 2012) and vascular endothelial cells (Kim et al., 2007).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Kim et al., 2007
In the citing paper
“In turn, metabolic and signaling changes seen in diabetes, such as high circulating glucose, altered lipid metabolism, and growth hormone axis perturbations, can promote senescent cell formation.”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
In the citing paper
“The ability of multiple individual components of this pathway to induce senescence has been recently shown, including growth hormone, IGF-1, and IGF binding protein 5 (IGFBP5) (27,28,41).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Normal somatic cells cultured in vitro have a limited ability to divide and then enter a state of irreversible proliferative arrest, termed replicative senescence ( Hayflick and Moorhead, 1961 ).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“SA--gal activity in cells was measured as described previously (Dimri et al., 1995).”
MethodOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“such as Ras (Serrano et al., 1997) or Raf (Zhu et al.”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundIGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 1×
“, 2003) or IGF1R (Holzenberger et al., 2003) increased life span.”
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750 · cited 2×
“The IGFBPs comprise a family of six proteins, IGFBP-1 to -6, that bind to IGFs with high affinity (Firth and Baxter, 2002).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundThe signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 2×
“Accumulating evidence suggests that p53 and p16/Rb tumor suppressor pathways are key regulators of the senescence response (Ferbeyre et al., 2002; Ben-Porath and Weinberg, 2005).”
BackgroundInduction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869 · cited 2×
“, 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
Background
Research works printed but not linked: 5
- Campbell P. G., 1997, Am. J. Physiol, 273, E1005
- Gui Y., 2001, J. Clin. Endocrinol. Metab, 86, 2104
- Nam T. J., 1997, Endocrinology, 138, 2972, 10.1210/endo.138.7.5230 · doi:10.1210/endo.138.7.5230 · Paper page
- Pekonen F., 1992, Cancer Res, 52, 5204
- Valentinis B., 1995, Mol. Endocrinol, 9, 361
Cited by
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
“Treatment of HUVECs with recombinant IGFBP3 or IGFBP5 is sufficient to slow down proliferation and provoke markers of senescenc”
BackgroundA senescent cell bystander effect: senescence‐induced senescence
Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin‐Ruiz, C., & von Zglinicki, T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00795.x · Cited by 755
“Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#onlineopen_Terms Accepted for publication 4 January 2012 ª 2012 The Authors Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 345 Aging Cell (2012…”
BackgroundInfluentialIGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
“Immunostaining for IGFBP-5 protein was dense within atherosclerotic plaques and especially around calcified areas (61).”
BackgroundCellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“Another IGFBP member, IGFBP5, has been found to increase during endothelial and fibroblast senescence and may induce cellular senescence on its own through a p53-dependent, p16independent mechanism (41).”
BackgroundCritical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385
“Significantly, premature senescence was induced when IGFBP5 was overexpressed in human umbilical vein endothelial cells (Seok Kim et al., 2007).”
BackgroundRedox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360
Radiation-Induced Endothelial Vascular Injury
Venkatesulu, B. P., Mahadevan, L. S., Aliru, M. L., Yang, X., Bodd, M. H., Singh, P. K., Yusuf, S. W., Abe, J.-I., & Krishnan, S. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.01.014 · Cited by 334
“That group also showed that IGFBP-induced senescence was mediated by p53 independent of p16 in ECs, but in other cells, p53 was required to initiate senescence, and p16 was required to maintain it (11).”
BackgroundBharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“…to be essential for both the early ROS increase, as well as the later senescence-associated-b-galactosidase activity, through STAT3-regulated soluble factor insulinlike growth factor binding protein 5 in both human fibroblasts (Udono et al., 2012) and vascular endothelial cells (Kim et al., 2007).”
BackgroundOncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
“IGFBP3, IGFBP5 Modulates IGF1 signaling pathway [111,112] IGFBP7 Modulates IGF signaling; downregulates Ras signaling [67] p38a-D176A, p38g-D179A Promotes p38MAPK signaling [62] STAT5 Promotes JAK–STAT signaling [43] Cyclin E Activated cyclin-dependent kinase-2: promotes G1 to S phase [34 ] E2F1 Transcription factor:…”
BackgroundCellular senescence controls fibrosis in wound healing
Jun, J.-I., & Lau, L. F. (2010) · Aging · doi:10.18632/aging.100201 · Cited by 255
“Additionally, several secreted proteins such as insulin-like growth factor binding proteins (IGFBPs), cytokines such as IL6, and ligands of the chemokine receptor CXCR2 have been shown to mediate or reinforce senescence [1,23,27,34,41,42].”
Background40 YEARS OF IGF1: IGF-binding proteins
Bach, L. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0254 · Cited by 252
Malaquin, N., Martinez, A., & Rodier, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.010 · Cited by 247
“…to reinforce the SAGA in an autocrine or paracrine manner (Acosta et al., 2013; Chen et al., 2015; Herranz et al., 2015; Hubackova et al., 2012; Kim et al., 2007; Kortlever et al., 2006; Kuilman et al., 2008; Kuilman and Peeper, 2009; Wajapeyee et al., AC C EP TE D M AN U SC R IP T 7/37 2008).”
Alterations in microRNA expression in stress-induced cellular senescence
Li, G., Luna, C., Qiu, J., Epstein, D. L., & Gonzalez, P. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.09.002 · Cited by 219
“…regulation of pathways involved in cellular senescence and exert important effects on cell cycle progression (Brosh et al., 2008; He et al., 2007; Kim et al., 2007a, 2007b; Kumamoto et al., 2008; Lafferty-Whyte et al., 2009; Poliseno et al., 2008; Tazawa et al., 2007; Wagner et al., 2008; Wang,…”
BackgroundSeverino, V, Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., Galderisi, U., & Chambery, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.445 · Cited by 214
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells
Cramer, C., Freisinger, E., Jones, R. K., Slakey, D. P., Dupin, C. L., Newsome, E. R., Alt, E. U., & Izadpanah, R. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0009 · Cited by 209
“Several genes related to glucose metabolism also changed in dASCs ( GCG , GCK , INSR , FBP1 , CEBPA , and IGFBP5 ) [26].”
Endothelial cells and the IGF system
Bach, L. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0215 · Cited by 196
miR-146a is modulated in human endothelial cell with aging
Vasa-Nicotera, M., Chen, H., Tucci, P., Yang, A. L., Saintigny, G., Menghini, R., Mahè, C., Agostini, M., Knight, R. A., Melino, G., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.034 · Cited by 185
“Recent studes have shown that the integrity of endothelial cells function is ompromised with aging and endothelial cell senescence plays pivtal roles in the evolution of age-associated cardiovascular diseases uch as atherosclerosis [2,3].”
BackgroundInfluentialIL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
Signaling Pathways of the Insulin-like Growth Factor Binding Proteins
Baxter, R. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad008 · Cited by 178
Calcium signaling alterations, oxidative stress, and autophagy in aging
Ureshino, R. P., Rocha, K. K., Lopes, G. S., Bincoletto, C., & Smaili, S. S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5777 · Cited by 143
“IGF-1 induces premature cellular senescence by inhibiting sirtuins and activating p53 (85), and it is also re-lated to the activation of mTOR (188).”
Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging
Hwang, H. J., Kim, N., Herman, A. B., Gorospe, M., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710135 · Cited by 149
Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0292 · Cited by 130
“functionally involved in p53-induced senescence (36-38)(Figure 3G).”
Cecchini, M. J., Hosein, K., Howlett, C. J., JOSEPH, M. G., & Mura, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0857-1 · Cited by 141
“2), plays an important role in the regulation of cellular senescence via a p53-dependent pathway [19].”
BackgroundmicroRNA and aging: A novel modulator in regulating the aging network
Chen, L.-H., Chiou, G., Chen, Y., Li, H.-Y., & Chiou, S. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.002 · Cited by 125
Mittal, S., Aslam, A., Doidge, R., Medica, R., & Winkler, G. S. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-11-0898 · Cited by 142
“Our data suggests that IGFBP5 may indeed exert its apoptotic effects via a p53 dependent mechanism, in support of Kim and co-workers who show similar data in human umbilical cord endothelial cells (Kim et al., 2007).”
BackgroundResultInfluentialInsulin-Like Growth Factor Binding Protein-5 in Physiology and Disease
Duan, C., & Allard, J. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00100 · Cited by 120
“IGFBP-5 expression is upregulated in atherosclerotic plaques and IGFBP-5 protein is found in large quantities associated with ECM within atherosclerotic plaques (56, 145).”
BackgroundSalminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Inflammation Research · doi:10.1007/s00011-021-01498-3 · Cited by 120
Shih, A., Adelson, R. P., Vashistha, H., Khalili, H., Nayyar, A., Puran, R., Herrera, R., Chatterjee, P. K., Lee, A. T., Truskinovsky, A. M., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02500-3 · Cited by 127
Role of IGF Binding Proteins in Regulating Metabolism
Clemmons, D. R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.019 · Cited by 120
Lee, S.-J., Jung, Y.-S., Yoon, M.-H., Kang, S.-M., Oh, A.-Y., Lee, J.-H., Jun, S.-Y., Woo, T.-G., Chun, H.-Y., Kim, S. K., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84164 · Cited by 102
“Thus, we next checked the effect of JH4 on oncogene-induced or growth factor–induced senescence (31, 32).”
BackgroundBinet, R., Ythier, D., Robles, A. I., Collado, M., Larrieu, D., Fonti, C., Brambilla, E., Brambilla, C., Serrano, M., Harris, C. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1016 · Cited by 101
Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq
Marthandan, S., Baumgart, M., Priebe, S., Groth, M., Schaer, J., Kaether, C., Guthke, R., Cellerino, A., Platzer, M., Diekmann, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154531 · Cited by 91
Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98
Age‐related changes in miR‐143‐3p:Igfbp5 interactions affect muscle regeneration
Soriano‐Arroquia, A., McCormick, R., Molloy, A., McArdle, A., & Goljanek‐Whysall, K. (2016) · Aging Cell · doi:10.1111/acel.12442 · Cited by 103
“The role of Igfbp5 in cellular senescence has also been previously shown (Kim et al., 2007).”
BackgroundSureshbabu, A., Okajima, H., Yamanaka, D., Tonner, E., Shastri, S., Maycock, J., Szymanowska, M., Shand, J. H., Takahashi, S., Beattie, J., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.092882 · Cited by 90
“However, in agreement with studies in human umbilical vein endothelial cells (Kim et al., 2007), we showed that IGFBP5 induced a sustained phosphorylation of p53 in MCF-7 cells, and p53, in turn, has been shown to inhibit phosphorylation of FAK (Golubovskaya et al., 2008).”
BackgroundResultLDL biochemical modifications: a link between atherosclerosis and aging
Alique, M., Luna, C., Carracedo, J., & Ramírez, R. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.29240 · Cited by 101
“of age-associated CVDs, such as atherosclerosis (71, 72).”
BackgroundLocal senolysis in aged mice only partially replicates the benefits of systemic senolysis
Farr, J. N., Saul, D., Doolittle, M. L., Kaur, J., Rowsey, J. L., Vos, S. J., Froemming, M. N., Lagnado, A. B., Zhu, Y., Weivoda, M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162519 · Cited by 81
“…osteo-cyte-specific senolysis suggests that synthetic activity (and/or longevity) of periosteal osteoblasts is regulated by Sn osteocytes perhaps via IGFBP5, a component of SenMayo (39) that has been previously shown to suppress bone formation on the periosteum but not the endosteum (43, 44).”
Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis
Chin, C., Ravichandran, R., Sanborn, K., Fleming, T. P., Wheatcroft, S. B., Kearney, M. T., Tokman, S., Walia, R., Smith, M. A., Flint, D. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100945 · Cited by 106
“20,21 24 In particular, IGFBP2 may play an important role in lung function as IGFBP2 levels can predict the risk of a rapid evolution of systemic sclerosis-induced interstitial lung disease.”
Kim, K. S., Kim, J. E., Choi, K. J., Bae, S., & Kim, D. H. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.859763 · Cited by 75
Self-citationAdipose Tissue Senescence and Inflammation in Aging is Reversed by the Young Milieu
Ghosh, A. K., O’Brien, M., Mau, T., Qi, N., & Yung, R. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly290 · Cited by 75
CD9 induces cellular senescence and aggravates atherosclerotic plaque formation
Cho, J. H., Kim, E.-C., Son, Y., Lee, D.-W., Park, Y. S., Choi, J. H., Cho, K., Kwon, K., & Kim, J.-R. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0537-9 · Cited by 77
Self-citationCellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
Yasuoka, H., Hsu, E., Ruiz, X. D., Steinman, R. A., Choi, A. M. K., & Feghali-Bostwick, C. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080991 · Cited by 75
Fate and state transitions during human blood vessel organoid development
Nikolova, M. T., He, Z., Seimiya, M., Jonsson, G., Cao, W., Okuda, R., Wimmer, R. A., Okamoto, R., Nikoloff, J. M., Dittrich, P. S., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.037 · Cited by 69
Regulation of cellular senescence by the essential caveolar component PTRF/Cavin-1
Bai, L., Deng, X., Li, J., Wang, M., Li, Q., An, W., Deli, A., & Cong, Y. (2011) · Cell Research · doi:10.1038/cr.2011.56 · Cited by 71
Functional Role of Cellular Senescence in Biliary Injury
Meng, L., Quezada, M., Levine, P., Han, Y., McDaniel, K., Zhou, T., Lin, E., Glaser, S., Meng, F., Francis, H., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.027 · Cited by 68
IGF Binding Protein-5 Induces Cell Senescence
Sanada, F., Taniyama, Y., Muratsu, J., Otsu, R., Shimizu, H., Rakugi, H., & Morishita, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00053 · Cited by 80
“Of the six IGFBPs, IGFBP-5 plays a critical role in the process of replicative and premature cell senescence (10, 11).”
BackgroundPark, K.-H., & Cho, K.-H. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr016 · Cited by 66
“In addition, the level of expression of insulin-like growth factor–binding protein (IGFBP)-5 was compared in the cell lysate via Western blot analysis using antihuman IGFBP-5 antibody (AF875; R & D Systems, Minneapolis, MN) according to a previous report (28).”
MethodAmuran, G. G., Karabulut, S., & Akkіprіk, M. (2012) · 癌症:英文版 · doi:10.5732/cjc.011.10405 · Cited by 68
Kološa, K., Motaln, H., Herold‐Mende, C. C., Koršič, M., & Lah, T. T. (2015) · Cell Transplantation · doi:10.3727/096368915x687787 · Cited by 66
“The MORC3 gene is involved in p53 induction of osteosarcoma cell’s senescence (43) and SERPINE1, a downstream p53 target (26), is known to stabilize IGFBP5 in senescent cells (22,34).”
BackgroundWang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Akkіprіk, M., Hu, L., Şahin, A., Hao, X., & Zhang, W. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-103 · Cited by 62
“Interestingly, a recent report [38] suggests that IGFBP-5 regulates vascular cellular senescence via a p53-dependent Deletion of 5 amino acids from 214 to 218 of IGFBP5 protein promotes MDA-MB-435 breast cancer cell motility Figure 6 Deletion of 5 amino acids from 214 to 218 of IGFBP5 protein promotes MDA-MB-435 breas…”
BackgroundRombouts, C., Aerts, A., Quintens, R., Baselet, B., El-Saghire, H., Harms-Ringdahl, M., Haghdoost, S., Janssen, A., Michaux, A., Yentrapalli, R., et al. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.905724 · Cited by 61
Cellular senescence: unravelling complexity
Passos, J. F., Simillion, C., Hallinan, J. S., Wipat, A., & von Zglinicki, T. (2009) · AGE · doi:10.1007/s11357-009-9108-1 · Cited by 71
“The secreted proteins insulin-like growth factor binding protein 3 and 5 (IGFBP3 and IGFBP5) have both been implicated in regulation of senescence in human umbilical vein endothelial cells (HUVEC; Kim et al. 2007a, b).”
BackgroundCellular senescence in ionizing radiation (Review)
Chen, Z., Cao, K., Xia, Y., Li, Y., Hou, Y., Wang, L., Li, L., Chang, L., & Li, W. (2019) · Oncology Reports · doi:10.3892/or.2019.7209 · Cited by 85
“Exogenous IGFBP-5 or IGFBP-5 overexpression induces premature senescence in human umbilical vein endothelial cells (HUVECs) in vitro , and knocking down IGFBP-5 can partially alter the senescence process in vitro (48).”
Hoeflich, A., David, R., & Hjortebjerg, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00388 · Cited by 61
Zuo, S., Liu, C., Wang, J., Wang, F., Xu, W., Cui, S., Yuan, L., Chen, X., Fan, W., Cui, M., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1153-y · Cited by 58
“Cyclin D-CDK4/6 and cyclin A/E-CDK2 are suggested to be involved in the phosphorylation of pRB during the G1/S transition of the cell cycle (Weinberg 1995; Kitagawa et al. 1996).”
MicroRNA‐216a induces endothelial senescence and inflammation via Smad3/IκBα pathway
Yang, S., Mi, X., Chen, Y., Feng, C., Hou, Z., Hui, R., & Zhang, W. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13567 · Cited by 64
“For example, it has been reported that exogenous IGF-binding protein 5 (IGFBP-5) markedly increased p53 expression after 90 minutes in HUVECs, while SA-b-gal activity was found to be elevated after prolonged treatment IGFBP-5 for 6 days.(24) miR-216a is expressed in several vascular cells, including monocytes/macropha…”
BackgroundWhat Happened to the IGF Binding Proteins?
Bach, L. A. (2017) · Endocrinology · doi:10.1210/en.2017-00908 · Cited by 58
“senescence via a p53-dependent pathway (35) and mediated the endothelial cell senescence induced by acti-”
BackgroundIdentification of evolutionarily conserved genetic regulators of cellular aging
Laschober, G. T., Ruli, D., Hofer, E., Muck, C., Carmona‐Gutierrez, D., Ring, J., Hutter, E., Ruckenstuhl, C., Micutkova, L., Brunauer, R., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00637.x · Cited by 54
“In turn, 15 genes taken from Table S3, including IGFBP-3, PTGS2, EGR1, FOS, ATM, DDIT3 (DE ‡ 20) are also highlighted as potential regulators of aging in the HAGR database.”
BackgroundInfluentialPKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53
Zhang, L., Li, W., Cao, L., Xu, J., Qian, Y., Chen, H., Zhang, Y., Kang, W., Gou, H., Wong, C. C., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0743-4 · Cited by 53
Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome
Massingham, L. J., Johnson, K. L., Scholl, T. M., Slonim, D. K., Wick, H. C., & Bianchi, D. W. (2014) · Human Genetics · doi:10.1007/s00439-014-1448-y · Cited by 52
“…associated with increased absorption (Kanatani et al. 2000), impairs osteoblast function (Devlin et al. 2002), and increases cellular senescence (Kim et al. 2007; Kojima et al. 2012). transgenic mice that overexpress IGFBP5 have inhibition of growth, increased neonatal mortality, and reduced…”
Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells
Sokolović, A., Sokolović, M., BOERS, W., Elferink, R. P. J. O., & Bosma, P. J. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-3 · Cited by 53
Adem, Y., Galderisi, U., & Alessio, N. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1148761 · Cited by 57
“Unlike the other IGF binding protein species, IGFBP-6 overexpression leads to increased cellular life span and proved to be a negative regulator of cellular senescence in human fibroblasts (Kim et al., 2007; Wajapeyee et al., 2008; Micutkova et al., 2011; Severino et al., 2013; Alessio et al., 2020; Vassilieva et al.,…”
BackgroundSenescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 50
Kim, H. J., Kim, K. S., Kim, S. H., Baek, S.-H., Kim, H. Y., Lee, C., & Kim, J.-R. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln055 · Cited by 50
Self-citationKrošl, J., Mamo, A., Chagraoui, J., Wilhelm, B. T., Girard, S., Louis, I., Lessard, J. A., Perreault, C., & Sauvageau, G. (2010) · Blood · doi:10.1182/blood-2010-03-273862 · Cited by 48
Colak, Y., Senates, E., Ozturk, O., Yilmaz, Y., Zemheri, E., Yilmaz Enc, F., Ulasoglu, C., Aksaray, S., Bozbeyoglu, S. G., Kiziltas, S., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834e8041 · Cited by 46
Xu, X., Huang, E., Luo, B., Cai, D., Zhao, X., Luo, Q., Jin, Y., Chen, L., Wang, Q., Liu, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701460rrr · Cited by 52
Lee, T., Paola, D. D., Malina, A., Mills, J. R., Kreps, A., Große, F., Tang, H., Zannis‐Hadjopoulos, M., Larsson, O. S., & Pelletier, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568535 · Cited by 49
“IGF2, which plays an essential role in growth and development, has been shown to be involved in senescence, along with other proteins in the IGF signaling pathway (71, 72).”
BackgroundAllan, G. J., Beattie, J., & Flint, D. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0269 · Cited by 56
“This IGFBP5–induced senescence was associated with the induction of the tumour suppressor p53 (Kim et al. 2007).”
InfluentialRaval, A. N., Schmuck, E. G., Tefera, G., Leitzke, C., Ark, C. V., Hei, D. J., Centanni, J. M., de Silva, R., Koch, J. M., Chappell, R. J., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.07.011 · Cited by 44
“A trend toward 2-fold or greater expression of 4 of 5 genes that are associated with cellular senescence was observed in the mobilization group [Insulin Like Growth Factor Binding Protein 5 (IGFBP5)(34), Calreticulin CALR(35), v-ets avian erythroblastosis virus E26 oncogene homolog 2 (ETS2)(36), growth arrest and DNA…”
BackgroundIGFBP5 mediates high glucose-induced cardiac fibroblast activation
Song, S. E., Kim, Y., Kim, J., Lee, D. H., Kim, J., & Park, S. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0194 · Cited by 43
“IGFBP5 is also involved in the cell differentiation of gingival epithelial cells (Hung et al. 2008) andmuscle cells (Ren et al. 2008), the senescence of human umbilical endothelial cells (Kim et al. 2007), and the apoptosis of hepatic stellate cells (Sokolovic et al. 2010).”
BackgroundSelf-citationXu, L., Wang, Y., Wang, J., Zhai, J., Ren, L., & Zhu, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179323 · Cited by 44
“It was documented that IGFBP-5 seems to play a critical role in the control of cellular senescence and inflammation [41].”
BackgroundWu, K., Zhou, M., Wu, Q., Yuan, S.-X., Wang, D., Jin, J.-L., Huang, J., Yang, J., Sun, W., Wan, L., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2800 · Cited by 42
“Insulin-like growth factor (IGF) signaling pathway plays an essential role in controlling cell differentiation, proliferation, apoptosis and aging (18).”
BackgroundSanada, F., Muratsu, J., Otsu, R., Shimizu, H., Koibuchi, N., Uchida, K., Taniyama, Y., Yoshimura, S., Rakugi, H., & Morishita, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-17508-6 · Cited by 41
Saquib, Q., Al-Salem, A. M., Siddiqui, M. A., Ansari, S. M., Zhang, X., & Al-Khedhairy, A. A. (2022) · Cells · doi:10.3390/cells11020195 · Cited by 43
“It has been validated earlier that IGFBP5 is the inducer of cellular senescence via the p53-dependent pathway [81].”
BackgroundMarthandan, S., Menzel, U., Priebe, S., Groth, M., Guthke, R., Platzer, M., Hemmerich, P., Kaether, C., & Diekmann, S. (2016) · Biological Research · doi:10.1186/s40659-016-0095-2 · Cited by 39
“The mRNA and protein expression levels of all three IGFBP family members were significantly upregulated in both HFF and MRC-5 senescent fibroblast strains, consistent with earlier observations [124–129].”
ResultIGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response
Sureshbabu, A., Okajima, H., Yamanaka, D., Shastri, S., Tonner, E., Rae, C. J., Szymanowska, M., Shand, J. H., Takahashi, S., Beattie, J., et al. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370882 · Cited by 39
Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts
Micutkova, L., Diener, T., Li, C., Rogowska-Wrzesinska, A., Mueck, C., Huetter, E., Weinberger, B., Grubeck-Loebenstein, B., Roepstorff, P., Zeng, R., et al. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.07.005 · Cited by 39
Azimzadeh, O., Moertl, S., Ramadan, R., Baselet, B., Laiakis, E. C., Sebastian, S., Beaton, D., Hartikainen, J. M., Kaiser, J. C., Beheshti, A., et al. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2110325 · Cited by 40
“At the gene expression level in these cells, the IGFBP5-related pathways were affected after irradiation (1.4 and 4.1 mGy/h), which is known to inhibit cell proliferation through a p53dependent mechanism (Kim et al. 2007; Rombouts et al. 2014).”
BackgroundInfluentialInhibitory effects of juglanin on cellular senescence in human dermal fibroblasts
Yang, H. H., Hwangbo, K., Zheng, M. S., Son, J., Kim, H. Y., Baek, S. H., Choi, H. C., Park, S., & Kim, J. (2014) · Journal of Natural Medicines · doi:10.1007/s11418-014-0817-0 · Cited by 36
Self-citationYang, H. H., Hwangbo, K., Zheng, M. S., Cho, J. H., Son, J., Kim, H. Y., Baek, S. H., Choi, H. C., Park, S., & Kim, J. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0344-2 · Cited by 42
“In addition to SA-b-gal activity, the proteins p53 and p21 are well-known markers of cellular senescence (Kim et al. 2007).”
BackgroundMethodSelf-citationIdentification of ageing-associated naturally occurring peptides in human urine
Nkuipou‐Kenfack, E., Bhat, A. V., Klein, J., Jankowski, V., Mullen, W., Vlahou, A., Dakna, M., Koeck, T., Schanstra, J. P., Zürbig, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5896 · Cited by 36
“Interactions between IGFBPs and IGFs generally have inhibitory effects on IGF-dependent signalling pathways potentially leading to augmented oxidative stress and inhibition of cellular proliferation, cellular differentiation and apoptosis [28, 29].”
BackgroundAntisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF/FGF pathway
Bae, Y., Choi, J. H., Nagy, A., Sung, H., & Kim, J. (2015) · The FASEB Journal · doi:10.1096/fj.15-278846 · Cited by 36
Self-citationActivated Factor X Induces Endothelial Cell Senescence Through IGFBP-5
Sanada, F., Taniyama, Y., Muratsu, J., Otsu, R., Iwabayashi, M., Carracedo, M., Rakugi, H., & Morishita, R. (2016) · Scientific Reports · doi:10.1038/srep35580 · Cited by 36
“Among IGFBPs, IGFBP-5 has been shown to inhibit the growth of breast cancer cells 28 , EC 10 , and fibroblasts 29 .”
Oguma, Y., Alessio, N., Aprile, D., Dezawa, M., Peluso, G., Bernardo, G. D., & Galderisi, U. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01280-4 · Cited by 36
“Studies have demonstrated that these IGFBPs can induce senescence at both the cellular and individual levels when administered to either the culture medium or living organisms [3, 16, 25, 40].”
BackgroundKim, H., Cho, J. H., Quan, H., & Kim, J.-R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.022 · Cited by 36
“Adriamycin treatment HDFs and HUVECs (PD < 28) were seeded at 1 10(5) cells in 60 mm dishes and incubated overnight and treated with adriamycin [22].”
MethodSelf-citationInhibitory effects of (−)-loliolide on cellular senescence in human dermal fibroblasts
Yang, H. H., Hwangbo, K., Zheng, M. S., Cho, J. H., Son, J., Kim, H. Y., Baek, S. H., Choi, H. C., Park, S., & Kim, J. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0435-0 · Cited by 34
“The expression of p53 and p21 proteins has been reported to increase during cellular senescence (Kim et al. 2007); therefore, we investigated whether (-)-loliolide decreases the p53 and p21 levels in adriamycin-treated cells.”
BackgroundMethodSelf-citationVijayan, A., Guha, D., Ameer, F., Kaziri, I., Mooney, C., Bennett, L., Sureshbabu, A., Tonner, E., Beattie, J., Allan, G. J., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.001 · Cited by 33
“IGFBP-5 expression is increased in the brain during hypoxia (O’Donnell et al., 2002) in Crohn’s disease (Zimmermann et al., 1997) in atherosclerotic plaques and in senescing cells (Kim et al., 2007).”
BackgroundMedeiros Tavares Marques, J. C., Cornélio, D. A., Nogueira Silbiger, V., Ducati Luchessi, A., de Souza, S., & Batistuzzo de Medeiros, S. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-16224-5 · Cited by 33
A molecular brain atlas reveals cellular shifts during the repair phase of stroke
Weber, R., Buil, B. A., Rentsch, N. H., Bosworth, A., Zhang, M., Kisler, K., Tackenberg, C., & Rust, R. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03437-z · Cited by 36
“It may be involved in the development of atherosclerosis by binding to extracellular matrix (ECM) components PAI-1 and osteopontin, which are found in atherosclerotic plaques and have been shown to promote atherosclerosis in loss-of-function studies [90–92].”
Conover, C. A., & Oxvig, C. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae029 · Cited by 39
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer
Alexander, P. B., Chen, R., Gong, C., Yuan, L., Jasper, J. S., Ding, Y., Markowitz, G. J., Yang, P., Xu, X., McDonnell, D. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754960 · Cited by 35
Modulation of vascular endothelial cell senescence by integrin β4
Sun, C., Liu, X., Qi, L., Xu, J., Zhao, J., Zhang, Y., Zhang, S., & Miao, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22262 · Cited by 33
Role of Insulin-Like Growth Factor Binding Proteins in Mammary Gland Development
Flint, D. J., Tonner, E., Beattie, J. M., & Allan, G. J. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9095-3 · Cited by 32
“This IGFBP-5-induced senescence was associated with induction of the tumour suppressor p53 [88].”
BackgroundLi, X., Feng, L., Zhang, C., Wang, J., Wang, S., & Hu, L. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2096-0 · Cited by 31
“, 2007a), and other studies have found that the knockdown of IGFBP4 or IGFBP5 induces a range of senescence-associated phenotypes (Kim et al., 2007b; Sanada et al., 2018).”
BackgroundResultThe Biological Process of Aging and the Impact of Ionizing Radiation
Al‐Jumayli, M., Brown, S. L., Chetty, I. J., Extermann, M., & Movsas, B. (2022) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.11.011 · Cited by 34
Alteration of Aging‐Dependent Micro RNA s in Idiopathic Pulmonary Fibrosis
Nho, R. S. (2015) · Drug Development Research · doi:10.1002/ddr.21272 · Cited by 30
“, 2009], is positively correlated to cellular senescence via p53-dependent mechanisms [Kim et al., 2007].”
Background
Metadata
- Authors
- Kim, K. S., Seu, Y. B., Baek, S.-H., Kim, M. J., Kim, K. J., Kim, J. H., & Kim, J.-R.
- Affiliations
- Kyungpook National University (KR)
- *Department of Biochemistry and Molecular Biology,
- Yeungnam University (KR)
- Venue
- Molecular Biology of the Cell
- Published
- 2007-11
- Volume
- 18
- Issue
- 11
- Pages
- 4543-4552
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2043568
- OpenAlex
- W2121682401
- Cited by
- 199
- References
- 76
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 18 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 10 · 2017: 13 · 2016: 12 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 8
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Biology of the Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Science and Engineering Foundation (R13-2005-005-01003-0)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- IGFBP-5, cellular senescence, p53, IGF signaling pathway, premature senescence, human umbilical vein endothelial cells, atherosclerosis, intimal plaque, p16, cell proliferation
- MeSH terms
- Cell Cycle, Cells, Cultured, DNA, DNA Damage, Humans, Protein Processing, Post-Translational, Umbilical Cord, Signal Transduction, Up-Regulation, Tumor Suppressor Protein p53, Cellular Senescence, Insulin-Like Growth Factor Binding Protein 5, MicroRNAs, Endothelial Cells, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.